High quality ELISAs
Developed and manufactured by Biomedica

Osteogenesis imperfecta (OI), also known as brittle bone disease, is a rare hereditary bone disorder with an estimated incidence of about 1 in 10,000 to 1 in 20,000 (1). It is characterized by low bone mass, increased bone fragility and recurrent fractures. The condition results from mutations that disrupt the synthesis and post-translational modification of [...]

We are excited to be soon attending the ECTS Congress in Innsbruck, Austria from May 23-26, 2025. Meet us at our banner exhibition “Biomedica´s Bone Marker ELISAs” and explore our kits including SCLEROSTIN, OPG, RANKL, FGF23, PERIOSTIN, and many others. We look forward to connecting with you! Join us at ECTS  Click here for more information about [...]

Sclerostin is an osteocyte-derived secreted glycoprotein that suppresses bone formation.  Our Sclerostin ELISA assay was highlighted in a recent study investigating the effect of vitamin D3, omega-3 fatty acids (omega-3s), and exercise on serum sclerostin levels and bone turnover markers. The researchers evaluated the effects of vitamin D3, omega-3s, and a simple home-based strength exercise [...]